Tokyo Tape
Sign in
← Takara Holdings

Quarterly report · Q2

2531.TEDINET S100S6LP
Period2023-04-01 → 2023-09-30
Filed2023-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥163.2bn2023-04-01 → 2023-09-30Cons.Net sales
Revenue¥350.7bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥164.3bn2022-04-01 → 2022-09-30Cons.Net sales
Operating income¥12.5bn2023-04-01 → 2023-09-30Cons.Operating income
Operating income¥19.6bn2022-04-01 → 2022-09-30Cons.Operating income
Ordinary income¥13.0bn2023-04-01 → 2023-09-30Cons.Ordinary income
Ordinary income¥38.7bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥20.0bn2022-04-01 → 2022-09-30Cons.Ordinary income
Profit before tax¥13.0bn2023-04-01 → 2023-09-30Cons.Income before income taxes
Profit before tax¥20.8bn2022-04-01 → 2022-09-30Cons.Income before income taxes
Net income (owners)¥8.0bn2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥21.2bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥10.9bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income¥9.0bn2023-04-01 → 2023-09-30Cons.Profit loss
Net income¥14.8bn2022-04-01 → 2022-09-30Cons.Profit loss
Total assets¥420.9bnat 2023-09-30Cons.Assets
Total assets¥399.2bnat 2023-03-31Cons.Assets
Total assets¥366.3bnat 2022-09-30Cons.Total assets (5-year summary)
Total liabilities¥148.8bnat 2023-09-30Cons.Liabilities
Total liabilities¥143.9bnat 2023-03-31Cons.Liabilities
Net assets / equity¥272.1bnat 2023-09-30Cons.Net assets
Net assets / equity¥255.3bnat 2023-03-31Cons.Net assets
Net assets / equity¥244.3bnat 2022-09-30Cons.Net assets (5-year summary)
Cash and deposits¥89.4bnat 2023-09-30Cons.Cash and deposits
Cash and deposits¥96.8bnat 2023-03-31Cons.Cash and deposits
Cash & equivalents¥84.4bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥91.8bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥56.0bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥75.7bnat 2022-03-31dCons.Cash and cash equivalents
Operating cash flow¥14.9bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥45.5bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥7.2bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥15.8bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥10.5bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥9.6bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥9.7bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥22.2bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥21.6bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥40.692023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥15.572023-07-01 → 2023-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥107.262022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥552022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥28.482022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio52.2%at 2023-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio51.1%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio53.3%at 2022-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 54
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-04-01 → 2023-09-30¥14.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-04-01 → 2023-09-30¥6.5bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2023-04-01 → 2023-09-30¥8.4bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-04-01 → 2023-09-30¥1.2bn
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-09-30−¥9.2bn
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-09-30−¥9.2bn
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-09-30−¥348m
jpcrp040300-q2r_E00396-000Takara Bio Groupreportable segmentrevenue2023-04-01 → 2023-09-30¥77.2bn
jpcrp040300-q2r_E00396-000Takara Bio Groupreportable segmentrevenue external2023-04-01 → 2023-09-30¥76.9bn
jpcrp040300-q2r_E00396-000Takara Bio Groupreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥282m
jpcrp040300-q2r_E00396-000Takara Bio Groupreportable segmentsegment profit2023-04-01 → 2023-09-30¥6.3bn
jpcrp040300-q2r_E00396-000Takara Healthcarereportable segmentrevenue2023-04-01 → 2023-09-30¥19.1bn
jpcrp040300-q2r_E00396-000Takara Healthcarereportable segmentrevenue external2023-04-01 → 2023-09-30¥19.1bn
jpcrp040300-q2r_E00396-000Takara Healthcarereportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥0
jpcrp040300-q2r_E00396-000Takara Healthcarereportable segmentsegment profit2023-04-01 → 2023-09-30¥1.4bn
jpcrp040300-q2r_E00396-000Takara Shuzo Groupreportable segmentrevenue2023-04-01 → 2023-09-30¥61.2bn
jpcrp040300-q2r_E00396-000Takara Shuzo Groupreportable segmentrevenue external2023-04-01 → 2023-09-30¥60.7bn
jpcrp040300-q2r_E00396-000Takara Shuzo Groupreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥486m
jpcrp040300-q2r_E00396-000Takara Shuzo Groupreportable segmentsegment profit2023-04-01 → 2023-09-30¥4.0bn
—segment totalrevenue2023-04-01 → 2023-09-30¥157.5bn
—segment totalrevenue external2023-04-01 → 2023-09-30¥156.7bn
—segment totalrevenue intersegment2023-04-01 → 2023-09-30¥768m
—segment totalsegment profit2023-04-01 → 2023-09-30¥11.6bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-09-30¥172.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-09-30¥163.2bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-09-30¥9.2bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-09-30¥12.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-09-30¥15.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-09-30¥6.7bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2022-09-30¥8.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-09-30¥1.2bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-09-30−¥9.4bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-09-30−¥9.4bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30−¥216m
jpcrp040300-q2r_E00396-000Takara Bio Groupreportable segmentrevenue2022-04-01 → 2022-09-30¥63.7bn
jpcrp040300-q2r_E00396-000Takara Bio Groupreportable segmentrevenue external2022-04-01 → 2022-09-30¥63.6bn
jpcrp040300-q2r_E00396-000Takara Bio Groupreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥121m
jpcrp040300-q2r_E00396-000Takara Bio Groupreportable segmentsegment profit2022-04-01 → 2022-09-30¥5.7bn
jpcrp040300-q2r_E00396-000Takara Healthcarereportable segmentrevenue2022-04-01 → 2022-09-30¥32.6bn
jpcrp040300-q2r_E00396-000Takara Healthcarereportable segmentrevenue external2022-04-01 → 2022-09-30¥32.6bn
jpcrp040300-q2r_E00396-000Takara Healthcarereportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥2m
jpcrp040300-q2r_E00396-000Takara Healthcarereportable segmentsegment profit2022-04-01 → 2022-09-30¥10.9bn
jpcrp040300-q2r_E00396-000Takara Shuzo Groupreportable segmentrevenue2022-04-01 → 2022-09-30¥61.8bn
jpcrp040300-q2r_E00396-000Takara Shuzo Groupreportable segmentrevenue external2022-04-01 → 2022-09-30¥61.3bn
jpcrp040300-q2r_E00396-000Takara Shuzo Groupreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥483m
jpcrp040300-q2r_E00396-000Takara Shuzo Groupreportable segmentsegment profit2022-04-01 → 2022-09-30¥2.1bn
—segment totalrevenue2022-04-01 → 2022-09-30¥158.1bn
—segment totalrevenue external2022-04-01 → 2022-09-30¥157.5bn
—segment totalrevenue intersegment2022-04-01 → 2022-09-30¥608m
—segment totalsegment profit2022-04-01 → 2022-09-30¥18.6bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-09-30¥173.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-09-30¥164.3bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-09-30¥9.4bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-09-30¥19.8bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 519
ItemContextValueUnit
Other nclPrior1YearInstant32288000000JPY
Other nclCurrentQuarterInstant37591000000JPY
Noncurrent liabilitiesPrior1YearInstant76401000000JPY
Noncurrent liabilitiesCurrentQuarterInstant71946000000JPY
LiabilitiesPrior1YearInstant143856000000JPY
LiabilitiesCurrentQuarterInstant148794000000JPY
Capital stockPrior1YearInstant13226000000JPY
Capital stockCurrentQuarterInstant13226000000JPY
Capital surplusPrior1YearInstant1994000000JPY
Capital surplusCurrentQuarterInstant1994000000JPY
Retained earningsPrior1YearInstant163825000000JPY
Retained earningsCurrentQuarterInstant164356000000JPY
Treasury stockPrior1YearInstant-1682000000JPY
Treasury stockCurrentQuarterInstant-1682000000JPY
Shareholders equityPrior1YearInstant177363000000JPY
Shareholders equityCurrentQuarterInstant177893000000JPY
Valuation difference on available for sale securitiesPrior1YearInstant12974000000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant17663000000JPY
Deferred gains or losses on hedgesPrior1YearInstant286000000JPY
Deferred gains or losses on hedgesCurrentQuarterInstant290000000JPY
Foreign currency translation adjustmentPrior1YearInstant13686000000JPY
Foreign currency translation adjustmentCurrentQuarterInstant24103000000JPY
Remeasurements of defined benefit plansPrior1YearInstant-359000000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant-261000000JPY
Valuation and translation adjustmentsPrior1YearInstant26588000000JPY
Valuation and translation adjustmentsCurrentQuarterInstant41795000000JPY
Non controlling interestsPrior1YearInstant51366000000JPY
Non controlling interestsCurrentQuarterInstant52382000000JPY
Net assetsPrior1YearInstant255318000000JPY
Net assetsCurrentQuarterInstant272071000000JPY
Liabilities and net assetsPrior1YearInstant399174000000JPY
Liabilities and net assetsCurrentQuarterInstant420865000000JPY
Net salesPrior1YTDDuration164279000000JPY
Net salesCurrentYTDDuration163172000000JPY
Cost of salesPrior1YTDDuration106400000000JPY
Cost of salesCurrentYTDDuration107713000000JPY
Gross profitPrior1YTDDuration57879000000JPY
Gross profitCurrentYTDDuration55459000000JPY
Selling general and administrative expensesPrior1YTDDuration38264000000JPY
Selling general and administrative expensesCurrentYTDDuration42995000000JPY
Operating incomePrior1YTDDuration19614000000JPY
Operating incomeCurrentYTDDuration12464000000JPY
Dividends income noiPrior1YTDDuration445000000JPY
Dividends income noiCurrentYTDDuration496000000JPY
Other noiPrior1YTDDuration452000000JPY
Other noiCurrentYTDDuration551000000JPY
Non operating incomePrior1YTDDuration898000000JPY
Non operating incomeCurrentYTDDuration1048000000JPY
Interest expenses noePrior1YTDDuration149000000JPY
Interest expenses noeCurrentYTDDuration184000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass